Last reviewed · How we verify
JCXH-105
At a glance
| Generic name | JCXH-105 |
|---|---|
| Sponsor | Immorna Biotherapeutics, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine (PHASE2)
- A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |